In that context, PolyPeptide appointed Stphane Varray as Chief Commercial Officer and as a member of the PolyPeptide Management Committee, effective January 2025.

PolyPeptide appoints Chief Commercial Officer Baar, 8 August 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, ...